Archive

ASH 2015: Highlights of the 57th American Hematological Society Meeting. Professor Ajay Gopal (Seattle Cancer Care Alliance), Professor Stephen Ansell (Mayo Clinic), Professor John Sweetenham (Huntsman Cancer Institute) and Professor Joseph Connors (Vancouver) share their highlights of a very busy ASH and New Year’s resolutions for their management of lymphoma in 2016. Click video image to view.

ESOT 2015: Will ‘Big Data’ shape transplantation? Act now! Dorry Segev (Johns Hopkins University) opened our eyes to the potential of Big Data in one of the outstanding plenary sessions at ESOT. He discusses in this video what transplant specialists should be acting on now and where this field is going in the future

ICML 2015 Video Interview: Thought leaders in lymphoma discuss highlights of ICML

Dr Andrew Davies, Southampton, UK, Professor John Radford, The University of Manchester, UK, Professor Peter Johnson, Southampton University, UK, Dr Karl Peggs, University College Hospital, London, Professor Stephen… read more.

Video Interview ICML 2015 with Professor Joseph Connors: Interim PET-based therapy should be considered routine clinical practice in early stage HL

Interview with Professor Joseph Connors, Vancouver, BC, Canada, who spoke for the motion in this key debate at ICML 2015.   Interview by Esther Drain.

Video Interview from the BSH 2015: Dr Graham Collins: Autologous vs Allogenic transplantation in Hodgkin lymphoma – where do they fit in?

Dr Graham Collins from the Oxford Cancer and Haematology Centre, Oxford, UK.

Video Interview and editorial from the BSH 2015: Professor Graham Jackson discusses the journey from despair to hope in multiple myeloma. Click on the image for interview and editorial.

Graham Jackson, Professor of Clinical haematology, Newcastle upon Tyne and former president of the British Society for Haematology (BSH). Article by Christine Clark: In the 1970s the prospect… read more.

Video Interview from the BSH 2015 Annual Meeting: Professor Graham Jackson gives his opinion on the controversial issue of whether we are nearing a cure for myeloma. Click on the image to hear interview.

Professor Graham Jackson, Royal Victoria Infirmary, Newcastle-Upon-Tyne, UK.

Does father know best?

Asthma symptoms affect millions of patients and are one of the leading causes of work and school absences. People who suffer from asthma know it’s a challenge to… read more.

ASH 2015: How do you see the newer agents being used in the up-front setting in HL? An interview with Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA. Click on the video image to view.

ASH 2014 Video Interview by Esther Drain: Highlights from the 2014 ASH Annual Meeting with Stephen Ansell, Robert Chen & Ajay Gopal

Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA.  Dr Robert Chen, City of Hope, Duarte, CA, USA.  Professor Ajay Gopal, University of Washington, WA, USA.

ASH 2014 Video Interview by Esther Drain: Hodgkin Lymphoma: Prognosis and Therapy. Professor Ajay Gopal (University of Washington) discusses where we are with prognostic biomarkers and interim PET scans to direct therapy in HL

by Thomas R. Collins: Pursuit of useful risk biomarkers in HL still a work-in-progress. The quest for biomarkers in classic Hodgkin lymphoma, to determine which patients are at a… read more.

ASH 2014 Video Interview by Esther Drain: Practice Changing News from ASH with Stephen Ansel, John Sweetenham & Ajay Gopal

Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA.  Professor John Sweetenham, Hunstman Cancer Institute, Saltlake City, USA.  Professor Ajay Gopal, University of Washington, WA, USA.